Hepatitis B

Hepatitis B News

  • ACIP Recommends Heplisav-B Vaccine for Adults Heplisav-B, a yeast-derived hepatitis B vaccine made with a novel adjuvant, is recommended for individuals aged 18 years and older, according to the Advisory Committee on Immunization Practices.
  • ILC 2018 Liver Cancer on the Rise in Backdrop of Undiagnosed Hep C The hepatitis C epidemic that started in the 1950s infected many patients who are now developing end-stage liver cancer, and the number of cases is growing, researchers report.

Hepatitis B Perspective